301507 民生健康
已收盘 10-09 15:00:00
资讯
新帖
简况
民生健康（301507）披露取得硫酸氨基葡萄糖胶囊药品批文公告，10月08日股价下跌0.97%
证券之星 · 10-08 17:47
民生健康（301507）披露取得硫酸氨基葡萄糖胶囊药品批文公告，10月08日股价下跌0.97%
民生健康最新公告：取得硫酸氨基葡萄糖胶囊药品批文
证券之星 · 09-30
民生健康最新公告：取得硫酸氨基葡萄糖胶囊药品批文
民生健康：三个募投项目延期 调整至2027年达产
格隆汇 · 09-30
民生健康：三个募投项目延期 调整至2027年达产
股市必读：民生健康新发布《关于2024年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属结果但股票暂不上市流通的公告》
证券之星 · 09-30
股市必读：民生健康新发布《关于2024年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属结果但股票暂不上市流通的公告》
民生健康（301507）披露限制性股票激励计划归属结果公告，9月28日股价下跌0.46%
证券之星 · 09-28
民生健康（301507）披露限制性股票激励计划归属结果公告，9月28日股价下跌0.46%
股市必读：民生健康新发布《财通证券股份有限公司关于杭州民生健康药业股份有限公司2026年半年度跟踪报告》
证券之星 · 09-11
股市必读：民生健康新发布《财通证券股份有限公司关于杭州民生健康药业股份有限公司2026年半年度跟踪报告》
民生健康（301507）2.46亿股限售股将于9月7日解禁，占总股本69%
证券之星 · 09-07
民生健康（301507）2.46亿股限售股将于9月7日解禁，占总股本69%
民生健康（301507）披露第二期回购公司股份实施完成公告，9月2日股价下跌3.82%
证券之星 · 09-02
民生健康（301507）披露第二期回购公司股份实施完成公告，9月2日股价下跌3.82%
【机构调研记录】嘉实基金调研民生健康、英杰电气等22只个股（附名单）
证券之星 · 09-01
【机构调研记录】嘉实基金调研民生健康、英杰电气等22只个股（附名单）
【机构调研记录】圆信永丰基金调研民生健康、志特新材等10只个股（附名单）
证券之星 · 09-01
【机构调研记录】圆信永丰基金调研民生健康、志特新材等10只个股（附名单）
民生健康（301507）披露部分首次公开发行前已发行股份上市流通提示性公告，8月31日股价下跌0.71%
证券之星 · 08-31
民生健康（301507）披露部分首次公开发行前已发行股份上市流通提示性公告，8月31日股价下跌0.71%
民生健康（301507）2026年中报简析：营收净利润同比双双增长
证券之星 · 08-29
民生健康（301507）2026年中报简析：营收净利润同比双双增长
民生健康（301507）披露2024年限制性股票激励计划归属条件成就及授予价格调整公告，8月27日股价上涨0.86%
证券之星 · 08-27
民生健康（301507）披露2024年限制性股票激励计划归属条件成就及授予价格调整公告，8月27日股价上涨0.86%
图解民生健康中报：第二季度单季净利润同比增长4.65%
证券之星 · 08-27
图解民生健康中报：第二季度单季净利润同比增长4.65%
民生健康2026年半年报：线上渠道拓展，增收不增利
蓝鲸财经 · 08-27
民生健康2026年半年报：线上渠道拓展，增收不增利
民生健康(301507.SZ)发布上半年业绩，归母净利润8339.43万元，同比增长1.20%
智通财经 · 08-27
民生健康(301507.SZ)发布上半年业绩，归母净利润8339.43万元，同比增长1.20%
民生健康（301507）披露公司及子公司取得发明专利证书公告，8月6日股价上涨0.25%
证券之星 · 08-06
民生健康（301507）披露公司及子公司取得发明专利证书公告，8月6日股价上涨0.25%
民生健康（301507）披露第二期以集中竞价交易方式回购公司股份进展公告，8月5日股价下跌0.73%
证券之星 · 08-05
民生健康（301507）披露第二期以集中竞价交易方式回购公司股份进展公告，8月5日股价下跌0.73%
民生健康（301507）披露第二期以集中竞价交易方式回购公司股份进展公告，7月2日股价下跌0.57%
证券之星 · 07-02
民生健康（301507）披露第二期以集中竞价交易方式回购公司股份进展公告，7月2日股价下跌0.57%
民生健康（301507）披露第二期回购股份进展公告，6月3日股价下跌0.86%
证券之星 · 06-03
民生健康（301507）披露第二期回购股份进展公告，6月3日股价下跌0.86%
加载更多
公司概况
公司名称：
杭州民生健康药业股份有限公司
所属行业：
医药制造业
上市日期：
2023-09-05
主营业务：
杭州民生健康药业股份有限公司的主营业务是药品、保健食品、功能性食品研发、生产、销售。公司的主要产品是21金维他®多维元素片。公司核心品牌“21金维他”已经发展成为国内维矿领域的领军品牌，品牌价值与市场影响力持续攀升：入选“健康产业•品牌发展指数•TOP品牌”，多次荣膺西普金奖药品榜、“西普会品牌榜金榜”、“品牌中国•中国医药品牌榜”、“西鼎奖•中国药品零售市场畅销品牌”。
发行价格：
10.00
{"stockData":{"symbol":"301507","market":"SZ","secType":"STK","nameCN":"民生健康","latestPrice":13.58,"timestamp":1791529380000,"preClose":13.29,"halted":0,"volume":3575400,"delay":0,"changeRate":0.0218,"floatShares":355000000,"shares":357000000,"eps":0.336,"marketStatus":"已收盘","change":0.29,"latestTime":"10-09 15:00:00","open":13.3,"high":13.59,"low":13.06,"amount":47576200,"amplitude":0.0399,"askPrice":13.58,"askSize":6,"bidPrice":13.57,"bidSize":25,"shortable":0,"etf":0,"ttmEps":0.336,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":13.29,"symbolType":"stock","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":14.62,"lowLimit":11.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":356554330,"isCdr":false,"pbRate":2.94,"roa":"--","peRate":40.416667,"roe":"5.12%","epsLYR":0.33,"committee":-0.877486,"marketValue":4842000000,"turnoverRate":0.0101,"status":0,"floatMarketCap":4823000000},"requestUrl":"/m/hq/s/301507","defaultTab":"news","newsList":[{"id":"2673925073","title":"民生健康（301507）披露取得硫酸氨基葡萄糖胶囊药品批文公告，10月08日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673925073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673925073?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:47","pubTimestamp":1791452870,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，民生健康报收于13.29元，较前一交易日下跌0.97%，最新总市值为47.39亿元。该股当日开盘13.5元，最高13.56元，最低13.21元，成交额达5627.16万元，换手率为1.19%。杭州民生健康药业股份有限公司近日收到国家药品监督管理局核准签发的硫酸氨基葡萄糖胶囊《药品补充申请批准通知书》，药品批准文号为国药准字H20255903，剂型为胶囊剂，规格为0.25g或0.314g，有效期18个月。该药品适用于原发性及继发性骨关节炎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800023902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203802","title":"民生健康最新公告：取得硫酸氨基葡萄糖胶囊药品批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203802","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671203802?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:11","pubTimestamp":1790763062,"startTime":"0","endTime":"0","summary":"民生健康(301507.SZ)公告称，公司收到国家药品监督管理局核准签发的硫酸氨基葡萄糖胶囊《药品补充申请批准通知书》。该药品适应症为原发性及继发性骨关节炎，此次取得药品批文有利于丰富公司产品品类，提升市场竞争力。药品销售业务易受行业政策变动、市场竞争等因素影响，存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000030127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671006208","title":"民生健康：三个募投项目延期 调整至2027年达产","url":"https://stock-news.laohu8.com/highlight/detail?id=2671006208","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671006208?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:10","pubTimestamp":1790763034,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671414652","title":"股市必读：民生健康新发布《关于2024年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属结果但股票暂不上市流通的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671414652","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671414652?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:16","pubTimestamp":1790705771,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，民生健康报收于13.32元，上涨1.68%，换手率1.05%，成交量3.75万手，成交额4996.9万元。公司公告汇总：民生健康完成限制性股票激励计划两次归属，合计归属1,061,000股，占总股本0.30%，归属股票暂不上市流通并限售3个月。归属对象共41人，其中首次授予39人，预留授予2人。授予价格调整为6.42元/股，股票来源于公司自二级市场回购的A股普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255185","title":"民生健康（301507）披露限制性股票激励计划归属结果公告，9月28日股价下跌0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670255185?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:38","pubTimestamp":1790606300,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，民生健康报收于13.1元，较前一交易日下跌0.46%，最新总市值为46.71亿元。该股当日开盘13.12元，最高13.28元，最低13.0元，成交额达4744.14万元，换手率为1.02%。公告显示，公司已完成2024年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期的归属，归属股票数量为1,061,000股，占总股本的0.30%。归属对象共41人，其中首次授予39人，预留授予2人。本次归属股票暂不上市流通，将在归属登记完成后限售3个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666979515","title":"股市必读：民生健康新发布《财通证券股份有限公司关于杭州民生健康药业股份有限公司2026年半年度跟踪报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666979515","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666979515?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:54","pubTimestamp":1789070063,"startTime":"0","endTime":"0","summary":"公司公告汇总：财通证券出具2026年半年度跟踪报告，确认民生健康募集资金项目进展与信息披露一致，未发现需关注问题。公司公告汇总财通证券股份有限公司关于杭州民生健康药业股份有限公司2026年半年度跟踪报告财通证券股份有限公司对杭州民生健康药业股份有限公司2026年上半年的持续督导工作进行了总结。报告期内无保荐代表人变更，公司及保荐人未被监管机构采取监管措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100011506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","301507","BK0239","601108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665412360","title":"民生健康（301507）2.46亿股限售股将于9月7日解禁，占总股本69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665412360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665412360?lang=zh_cn&edition=full","pubTime":"2026-09-07 08:01","pubTimestamp":1788739282,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，民生健康于9月7日将有2.46亿股限售股份解禁，为公司首发原股东限售股份，占公司总股本69.0%。最近一年内，该股累计解禁98.3万股，占总股本的0.28%。本次解禁后，公司还有34.5万股限售股份，占总股本0.1%。民生健康主营业务：维生素与矿物质类非处方药品和保健食品研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700001115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810761","title":"民生健康（301507）披露第二期回购公司股份实施完成公告，9月2日股价下跌3.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810761","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810761?lang=zh_cn&edition=full","pubTime":"2026-09-02 23:07","pubTimestamp":1788361636,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，民生健康报收于12.6元，较前一交易日下跌3.82%，最新总市值为44.93亿元。公告显示，杭州民生健康药业股份有限公司于2025年10月28日召开董事会，审议通过第二期回购公司股份方案，拟以集中竞价交易方式回购股份用于股权激励。截至2026年9月1日，公司已累计回购股份2,322,600股，占公司总股本的0.65%，支付金额为34,185,596元，回购方案已实施完毕。回购股份将全部用于股权激励，若未能在3年内使用完毕，未使用部分将予以注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664210889","title":"【机构调研记录】嘉实基金调研民生健康、英杰电气等22只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2664210889","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664210889?lang=zh_cn&edition=full","pubTime":"2026-09-01 08:19","pubTimestamp":1788221998,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月31日披露的机构调研信息，嘉实基金近期对22家上市公司进行了调研，相关名单如下：1）民生健康 个股亮点：公司小金维他品牌定位“儿童全营养”，与环球影视“小黄人”IP合作，新包装系列已陆续上架。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100007675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300820","301507","BK0239","BK0224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664088943","title":"【机构调研记录】圆信永丰基金调研民生健康、志特新材等10只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2664088943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664088943?lang=zh_cn&edition=full","pubTime":"2026-09-01 08:18","pubTimestamp":1788221938,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月31日披露的机构调研信息，圆信永丰基金近期对10家上市公司进行了调研，相关名单如下：1）民生健康 个股亮点：公司小金维他品牌定位“儿童全营养”，与环球影视“小黄人”IP合作，新包装系列已陆续上架。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100007662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0256","300986","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001131","title":"民生健康（301507）披露部分首次公开发行前已发行股份上市流通提示性公告，8月31日股价下跌0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663001131?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:31","pubTimestamp":1788186689,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，民生健康报收于12.53元，较前一交易日下跌0.71%，最新总市值为44.68亿元。近日，杭州民生健康药业股份有限公司发布关于部分首次公开发行前已发行股份上市流通的提示性公告。解除限售股份数量为246,022,472股，占公司总股本的69.00%，限售期为36个月。本次解除限售后，公司有限售条件股份减少至345,000股，无限售条件股份相应增加。相关股东已履行股份锁定承诺，不存在违规情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663228016","title":"民生健康（301507）2026年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2663228016","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663228016?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:52","pubTimestamp":1787957575,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期民生健康发布2026年中报。根据财报显示，民生健康营收净利润同比双双增长。截至本报告期末，公司营业总收入5.35亿元，同比上升15.76%，归母净利润8339.43万元，同比上升1.2%。去年的净利率为15.49%，算上全部成本后，公司产品或服务的附加值高。本文数据来源于民生健康2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662278701","title":"民生健康（301507）披露2024年限制性股票激励计划归属条件成就及授予价格调整公告，8月27日股价上涨0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662278701","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662278701?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:28","pubTimestamp":1787830105,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，民生健康报收于12.9元，较前一交易日上涨0.86%，最新总市值为46亿元。该股当日开盘12.75元，最高12.94元，最低12.73元，成交额达3082.74万元，换手率为2.18%。近日，杭州民生健康药业股份有限公司披露第二届董事会第十四次会议决议公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770603","title":"图解民生健康中报：第二季度单季净利润同比增长4.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770603","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662770603?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:49","pubTimestamp":1787827795,"startTime":"0","endTime":"0","summary":"证券之星消息，民生健康2026年中报显示，上半年度公司主营收入5.35亿元，同比上升15.76%；归母净利润8339.43万元，同比上升1.2%；扣非净利润8622.59万元，同比上升8.69%；其中2026年第二季度，公司单季度主营收入2.18亿元，同比上升14.06%；单季度归母净利润2061.6万元，同比上升4.65%；单季度扣非净利润1968.67万元，同比上升8.13%；负债率17.68%，投资收益407.49万元，财务费用-334.22万元，毛利率55.17%。财报数据概要请见下图:本文数据来源于民生健康2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700044998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708002","title":"民生健康2026年半年报：线上渠道拓展，增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708002","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662708002?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:06","pubTimestamp":1787825160,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月27日讯，8月27日，民生健康 公布2026年中报，公司依托维生素矿物质补充剂核心业务，受益于健康意识提升及线上渠道拓展，报告期业绩保持稳健增长；同时，销售费用投入加大带动品牌曝光，但投资收益减少及公允价值变动拖累利润表现，整体呈现“增收不增利”特征。该板块线下经销与线上直销双轮驱动，其中线上直销食品业务收入同比增长87.38%，毛利率高达73.91%，成为拉动营收增长的重要引擎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787818383566717776","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662177298","title":"民生健康(301507.SZ)发布上半年业绩，归母净利润8339.43万元，同比增长1.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662177298","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662177298?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:01","pubTimestamp":1787821299,"startTime":"0","endTime":"0","summary":"智通财经APP讯，民生健康(301507.SZ)发布2026年半年度报告，报告期内，公司实现营业收入5.35亿元，同比增长15.76%。实现归属于上市公司股东的净利润8339.43万元，同比增长1.20%。实现归属于上市公司股东的扣除非经常性损益的净利润8622.59万元，同比增长8.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657586466","title":"民生健康（301507）披露公司及子公司取得发明专利证书公告，8月6日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657586466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657586466?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:47","pubTimestamp":1786027634,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，民生健康报收于12.2元，较前一交易日上涨0.25%，最新总市值为43.5亿元。该股当日开盘12.18元，最高12.22元，最低12.07元，成交额达3596.17万元，换手率为2.69%。近日，杭州民生健康药业股份有限公司及子公司民生中科嘉亿（浙江）生物工程有限公司、民生中科嘉亿（山东）生物工程有限公司获得三项国家知识产权局颁发的发明专利证书。上述专利尚未应用于公司产品。专利的取得有利于公司完善知识产权保护体系，增强核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600040226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657523672","title":"民生健康（301507）披露第二期以集中竞价交易方式回购公司股份进展公告，8月5日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523672","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657523672?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:31","pubTimestamp":1785940275,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，民生健康报收于12.17元，较前一交易日下跌0.73%，最新总市值为43.39亿元。该股当日开盘12.26元，最高12.32元，最低12.08元，成交额达4480.99万元，换手率为3.34%。公司于近日披露《关于第二期以集中竞价交易方式回购公司股份的进展公告》。公告显示，截至2026年7月31日，杭州民生健康药业股份有限公司通过集中竞价交易方式累计回购股份2,320,000股，占公司总股本的0.65%。回购实施期限为自董事会审议通过之日起12个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648468982","title":"民生健康（301507）披露第二期以集中竞价交易方式回购公司股份进展公告，7月2日股价下跌0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648468982","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648468982?lang=zh_cn&edition=full","pubTime":"2026-07-02 23:03","pubTimestamp":1783004600,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，民生健康报收于12.3元，较前一交易日下跌0.57%，最新总市值为43.86亿元。该股当日开盘12.33元，最高12.55元，最低12.19元，成交额达5262.4万元，换手率为3.87%。近日，民生健康发布《关于第二期以集中竞价交易方式回购公司股份的进展公告》。公告显示，截至2026年6月30日，公司通过集中竞价交易方式累计回购股份2,220,000股，占公司总股本的0.62%。公司回购行为符合相关法规及既定方案。后续将根据市场情况继续实施回购，并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640265908","title":"民生健康（301507）披露第二期回购股份进展公告，6月3日股价下跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640265908","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640265908?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:44","pubTimestamp":1780479857,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘，民生健康报收于12.69元，较前一交易日下跌0.86%，最新总市值为45.25亿元。该股当日开盘12.81元，最高12.83元，最低12.58元，成交额达3158.43万元，换手率为2.26%。近日，民生健康披露《关于第二期以集中竞价交易方式回购公司股份的进展公告》。本次回购用于股权激励，回购价格不超过21.06元/股，实施期限为自董事会审议通过之日起12个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791583355709,"stockEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1068},{"period":"3month","weight":0.1223},{"period":"6month","weight":-0.0327},{"period":"1year","weight":-0.0003},{"period":"ytd","weight":-0.1051}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州民生健康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17584人(较上一季度减少11.78%)","perCapita":"20197股","listingDate":"2023-09-05","address":"浙江省杭州市临平区东湖街道新天路101号","registeredCapital":"35655万元","survey":" 杭州民生健康药业股份有限公司的主营业务是药品、保健食品、功能性食品研发、生产、销售。公司的主要产品是21金维他®多维元素片。公司核心品牌“21金维他”已经发展成为国内维矿领域的领军品牌，品牌价值与市场影响力持续攀升：入选“健康产业•品牌发展指数•TOP品牌”，多次荣膺西普金奖药品榜、“西普会品牌榜金榜”、“品牌中国•中国医药品牌榜”、“西鼎奖•中国药品零售市场畅销品牌”。","listedPrice":10},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"民生健康(301507)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供民生健康(301507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"民生健康,301507,民生健康股票,民生健康股票老虎,民生健康股票老虎国际,民生健康行情,民生健康股票行情,民生健康股价,民生健康股市,民生健康股票价格,民生健康股票交易,民生健康股票购买,民生健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"民生健康(301507)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供民生健康(301507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}